Smith & Nephew plc (SNN)
NYSE: SNN · Real-Time Price · USD
25.29
+0.24 (0.96%)
Jan 17, 2025, 4:00 PM EST - Market closed
Smith & Nephew Revenue
Smith & Nephew had revenue of $2.83B in the half year ending June 29, 2024, with 8.73% growth. This brings the company's revenue in the last twelve months to $5.64B, up 5.48% year-over-year. In the year 2023, Smith & Nephew had annual revenue of $5.55B with 6.40% growth.
Revenue (ttm)
$5.64B
Revenue Growth
+5.48%
P/S Ratio
n/a
Revenue / Employee
$295,687
Employees
19,081
Market Cap
11.03B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5.55B | 334.00M | 6.40% |
Dec 31, 2022 | 5.22B | 3.00M | 0.06% |
Dec 31, 2021 | 5.21B | 652.00M | 14.30% |
Dec 31, 2020 | 4.56B | -578.00M | -11.25% |
Dec 31, 2019 | 5.14B | 234.00M | 4.77% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.22B |
SNN News
- 6 days ago - Smith+Nephew's ALLEVYN™ LIFE Sacrum Foam Dressing and LEAF™ Patient Monitoring System receive ‘favorable' Evidence Bar™ ratings from ECRI for pressure injury prevention - GlobeNewsWire
- 6 days ago - Topical Scar Treatment Market to Grow from $1.71 Billion in 2024 to $5.91 Billion by 2035 - Dominated by Smith & Nephew, Molnlycke Health Care, Alliance Pharma, HRA Pharma, and Rejuvaskin - GlobeNewsWire
- 4 weeks ago - Smith+Nephew introduces CORIOGRAPH™ Pre-Op Planning and Modeling Services for Total Hip Arthroplasty - GlobeNewsWire
- 5 weeks ago - Smith+Nephew expands AETOS™ Shoulder System with new stemless option for anatomic shoulder arthroplasty - GlobeNewsWire
- 2 months ago - Big investors call for break-up of Smith & Nephew, FT reports - Reuters
- 2 months ago - Smith & Nephew: Ready To Reap Demographic, Turnaround Dividends - Seeking Alpha
- 2 months ago - Smith & Nephew plc (SNN) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha
- 2 months ago - Smith & Nephew slashes annual revenue forecast on weak China - Reuters